Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: A pilot study

Oncology Nursing Forum

Volumn 33, Issue 4, 2006, Pages 775-783

  Payne, Judith K ^a   Piper, Barbara F ^b   Rabinowitz, Ian ^c   Zimmerman, M Bridget ^d  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; DEPRESSION; FATIGUE; FEMALE; HUMAN; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SLEEP DISORDER;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; DEPRESSION; FATIGUE; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SLEEP DISORDERS;

EID: 33746196479     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/06.ONF.775-783     Document Type: Article

References (43)

1. Aistars, J. (1987). Fatigue in the cancer patient: A conceptual approach to a clinical problem. Oncology Nursing Forum, 14(6), 25-30.
2. Ancoli-Israel, S., Moore, P.J., & Jones, V. (2001). The relationship between fatigue and sleep in cancer patients: A review. European Journal of Cancer Care, 10, 245-255.
3. Berger, A.M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25, 51-62.
4. Berger, A.M., & Higginbotham, P. (2000). Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncology Nursing Forum, 27, 1443-1448.
5. Berger, A.M., Parker, K.P., Young-McCaughan, S., Mallory, G.A., Barsevick, A.M., Beck, S.L., et al. (2005). Sleep-wake disturbances in people with cancer and their caregivers: State of the science. Oncology Nursing Forum, 32, E96-E126.
6. Berger, A.M., VonEssen, S., Kuhn, B.R., Piper, B.F., Farr, L., Agrawal, S., et al. (2002). Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 29, 1431-1441.
7. Birdsall, T.C. (1996). The biological effects and clinical uses of the pineal hormone melatonin. Alternative Medicine Review, 1, 94-102.
8. Carlson, R.W., Anderson, B.O., Burstein, H.J., Cox, C.E., Edge, S.B., Farrar, W.B., et al. (2005). Breast cancer. Journal of the National Comprehensive Cancer Network, 3, 238-289.
9. Carpenter, J.S., Elam, J.L., Ridner, S.H., Carney, P.H., Cherry, G.J., & Cucullu, H.L. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncology Nursing Forum, 31, 591-598.
10. Caudell, A. (2000). Psychoneuroimmunology: Foundations for mind-body interactions. In M.L. Winningham & M. Barton-Burke (Eds.), Fatigue in cancer: A multidimensional approach (pp. 123-149). Sudbury, MA: Jones and Bartlett.
11. Claustrat, B., Brun, J., & Chazot, G. (2005). The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews, 9, 11-24.
12. Cleeland, C.S. (2001). Cancer-related fatigue: New directions for research. Introduction. Cancer, 92(6, Suppl.), 1657-1661.
13. Cleeland, C.S., Bennett, G.J., Dantzer, R., Dougherty, P.M., Dunn, A.J., Meyers, C.A., et al. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer systems. Cancer, 97, 2919-2925.
14. Cupp, M.J. (1997). Melatonin. American Family Physician, 56, 1421-1425.
15. Given, C.W., Stommel, M., Given, B., Osuch, J., Kurtz, M.E., & Kurtz, J.C. (1993). The influence of cancer patients' symptoms and functional states on patients' depression and family caregivers' reaction and depression. Health Psychology, 12, 277-285.
16. Grandjean, E.P. (1970). Fatigue. American Industrial Hygiene Association Journal, 31, 401-411.
17. Gutstein, H.B. (2001). The biologic basis of fatigue. Cancer, 92(6, Suppl.), 1678-1683.
18. Haylock, P.J., & Hart, L.K. (1979). Fatigue in patients receiving localized radiation. Cancer Nursing, 2, 461-467.
19. Irvine, D., Vincent, L., Graydon, J.E., Bubela, N., & Thompson, L. (1994). The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nursing, 17, 367-378.
20. Jacobsen, P.B., Hann, D.M., Azzarello, L.M., Horton, J., Balducci, L., & Lyman, G.H. (1999). Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. Journal of Pain and Symptom Management, 18, 233-242.
21. Jones, T.H., Wadler, S., & Hupart, K.H. (1998). Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha. Seminars in Oncology, 25(1, Suppl. 1), 54-63.
22. Mock, V. (2004). Evidence-based treatment of cancer-related fatigue. Journal of the National Cancer Institute Monographs, 32, 112-118.
23. Norris, C. (1982). Tiredness and fatigue. In C. Norris (Ed.), Concept clarification in nursing (pp. 321-326). Rockville, MD: Aspen Systems.
24. Payne, J., Piper, B., Rabinowitz, I., & Zimmerman, B. (2003). Biomarkers, sleep, and fatigue characteristics in breast cancer patients and healthy women [Abstract]. In Proceedings from the Seventh National Conference on Cancer Nursing Research (p. 158). Pittsburgh, PA: Oncology Nursing Society.
25. Payne, J.K. (2002). The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy. Oncology Nursing Forum, 29, 1334-1340.
26. Payne, J.K. (2004). A neuroendocrine-based regulatory fatigue model. Biological Research for Nursing, 6, 141-150.
27. Pickard-Holley, S. (1991). Fatigue in cancer patients. A descriptive study. Cancer Nursing, 14, 13-19.
28. Piper, B.F. (2003). Fatigue. In V. Carrieri-Kohlman, A.M. Lindsey, & C.M. West (Eds.), Pathophysiological phenomena in nursing: Human responses to illness (3rd ed., pp. 209-234). St. Louis, MO: Saunders.
29. Piper, B.F., Dibble, S.L., Dodd, M.M., Weiss, M.C., Slaughter, R.E., & Paul, S.M. (1998). The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25, 677-684.
30. Piper, B.F., Lindsey, A.M., & Dodd, M.J. (1987). Fatigue mechanisms in cancer patients: Developing nursing theory. Oncology Nursing Forum, 14(6), 17-23.
31. Raab, C., Weidmann, E., Schmidt, A., Bergmann, L., Badenhoop, K., Usadel, K.H., et al. (1999). The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology, 50, 37-44.
32. Radloff, L.S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
33. Redwine, L., Hauger, R.L., Gillin, J.C., & Irwin, M. (2000). Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. Journal of Clinical Endocrinology and Metabolism, 85, 3597-3603.
34. Savard, J., & Morin, C.M. (2001). Insomnia in the context of cancer: A review of a neglected problem. Journal of Clinical Oncology, 19, 895-908.
35. Schneider, S.M., Prince-Paul, M., Allen, M.J., Silverman, P., & Talaba, D. (2004). Virtual reality as a distraction intervention for women receiving chemotherapy. Oncology Nursing Forum, 31, 81-88.
36. Sephton, S.E., Sapolsky, R.M., Kraemer, H.C., & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute, 92, 994-1000.
37. Silberfarb, P.M., Hauri, P.J., Oxman, T.E., & Schnurr, P. (1993). Assessment of sleep in patients with lung cancer and breast cancer. Journal of Clinical Oncology, 11, 997-1004.
38. Stricker, C.T., Drake, D., Hoyer, K.A., & Mock, V. (2004). Evidence-based practice for fatigue management in adults with cancer: Exercise as an intervention. Oncology Nursing Forum, 31, 963-976.
39. Touitou, Y., Bogdan, A., Levi, F., Benavides, M., & Auzeby, A. (1996). Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens. British Journal of Cancer, 74, 1248-1252.
40. Vaughan, G.M. (1993). New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. Journal of Pineal Research, 15, 88-103.
41. Vgontzas, A.N., & Chrousos, G.P. (2002). Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders. Endocrinology and Metabolism Clinics of North America, 31, 15-36.
42. Winningham, M.L., & Barton-Burke, M. (Eds.). (2000). Fatigue in cancer: A multidimensional approach. Sudbury, MA: Jones and Bartlett.
43. Winningham, M.L., Nail, L.M., Burke, M.B., Brophy, L., Cimprich, B., Jones, L.S., et al. (1994). Fatigue and the cancer experience: The state of the knowledge. Oncology Nursing Forum, 21, 23-36.